CSIMarket
 
Biogen Inc   (BIIB)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 
Price: $266.6000 $-3.25 -1.204%
Day's High: $269.28 Week Perf: -3.84 %
Day's Low: $ 267.19 30 Day Perf: -4.26 %
Volume (M): 33 52 Wk High: $ 363.92
Volume (M$): $ 8,875 52 Wk Avg: $279.20
Open: $273.00 52 Wk Low: $223.25



 Market Capitalization (Millions $) 41,056
 Shares Outstanding (Millions) 154
 Employees 7,400
 Revenues (TTM) (Millions $) 13,445
 Net Income (TTM) (Millions $) 4,061
 Cash Flow (TTM) (Millions $) -1,652
 Capital Exp. (TTM) (Millions $) 477

Biogen Inc
Biogen Idec creates new standards of care in oncology and immunology. As a global leader in the development, manufacturing, and commercialization of novel therapies, we transform scientific discoveries into advances in human healthcare. We currently have four commercial products: AVONEX® (Interferon beta-1a) for the treatment of relapsing multiple sclerosis, also known as MS, RITUXAN® (rituximab) and ZEVALIN® (ibritumomab tiuxetan), both of which treat certain B-cell non-Hodgkin’s lymphomas, also referred to as B-cell NHLs, and AMEVIVE® (alefacept) for the treatment of adult patients with moderate-to-severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy.


   Company Address: 225 Binney Street Cambridge 2142 MA
   Company Phone Number: 679-2000   Stock Exchange / Ticker: NASDAQ BIIB
   BIIB is expected to report next financial results on April 22, 2021.


Customers Net Income grew by BIIB's customers Net margin grew to

15.09 %

3.71 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ABBV   -1.81%    
AMGN   -2.63%    
PFE        1.75% 
ABT   -2.57%    
MRK   -1.76%    
BMY   -2.94%    
• View Complete Report
   



Abb Ltd

Abb Ltd announced fiscal time frame ending Dec 31 2020 operating surplus of $1593 millions

Despite weak Sales in the fiscal time frame ending Dec 31 2020, company has managed to improve its earnings per share, earnings per share more than doubled by 262.69 % to $2.43 per share while Sales fell by -6.59% to $26.13 billions, year on year.

from the preceding quarter from $0.00 per share, from $0.00 millions.
In the fiscal year 2020, Abb Ltd reported Sales of $26.13 billions and net income of $5.21 billions.

Eps surged by 262.69 % to $2.43 per share from $0.67 in the previous fiscal year, while Sales decreased by -6.59 % from $27.98 billions a year ago.

Teledyne Technologies Inc

Income Increased by 12.98 %, Sales Down Slightly

Although revenue fell in the fourth quarter of 2020, company managed to grow its earnings per share, eps grew by 12.98 % to $3.46 per share while Sales fell by -2.98% to $809.30 millions, year on year.

From the preceding quarter, earnings grew from $2.48 per share and Sales advanced by 8.05 % from $749.00 millions.
In the fiscal year 2020, Teledyne Technologies Inc reported Sales of $3.09 billions and net income of $401.90 millions.

Eps decreased by -1.03 % to $10.62 per share from $10.73 in the previous fiscal year, while Sales decreased by -2.45 % from $3.16 billions a year ago.

Healthstream Inc

Healthstream Inc announced fourth quarter of 2020 operating profit of $1.136 millions

Healthstream Inc realized a deterioration in earnings per share by -74.25% to $0.03 and Sales decrease by -1.4% to $61.82 millions in the fourth quarter of 2020, year on year.

From the preceding quarter, profit plummeted from $0.08 per share and Sales increased by 1.54 % from $60.88 millions.
In the fiscal year 2020, Healthstream Inc reported Sales of $244.83 millions and net income of $14.09 millions.

Profits per share fell by -10.2 % to $0.44 per share from $0.49 in the previous fiscal year, while Sales decreased by -3.65 % from $254.11 millions a year ago.

Align Technology inc

Profits Soar by 162.33 % but Revenues Dive

Company reported strong income growth of 162.33 % to $1.99 per share, on fading Sales of -30.38% to $834.52 millions in the fourth quarter of 2020, compared to previous year.

In contrast to the third quarter Sales advanced by 13.67 % from $734.14 millions and income per share increased by 12.97 % from $1.76 per share.
In the fiscal year 2020, Align Technology Inc reported Sales of $2.47 billions and net income of $1.78 billions.

Eps surged by 305.24 % to $22.41 per share from $5.53 in the previous fiscal year, while Sales increased by 2.71 % from $2.41 billions a year ago.

Alliance Data Systems Corp

Income Tumbles by -87.95%, Sales Faded

Sales contraction of -24.04% caused drop in earnings by -87.95% for the fourth quarter of 2020. Company posted results of $1.11 billions in Sales this compares to $1.46 billions a year ago and eps of $0.25 per share compared to 2.06 in previous year.

In contrast to the third quarter Sales increased by 5.64 % from $1.05 billions and eps dropped by -91.11% from $2.79 per share.
In the fiscal year 2020, Alliance Data Systems Corp reported Sales of $4.52 billions and net income of $213.70 millions.

Profits per share fell by -18.32 % to $4.46 per share from $5.46 in the previous fiscal year, while Sales fell by -18.99 % from $5.58 billions a year ago.






 

Biogen Inc 's Segments
 
AVONEX
 Segment    29.25 % of total Revenue
TYSABRI
 Segment    22.02 % of total Revenue
PLEGRIDY
 Segment    3.54 % of total Revenue
Other
 Segment    -3.94 % of total Revenue
FAMPYRA
 Segment    1 % of total Revenue
TECFIDERA
 Segment    42 % of total Revenue
ALPROLIX
 Segment    2.59 % of total Revenue
ELOCTATE
 Segment    3.53 % of total Revenue
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Biogen Inc does not provide revenue guidance.

Earnings Outlook
Alliance Data Systems Corp does not provide earnings estimates.

 
Geographic Revenue Dispersion
United States 74.12 %
Europe 15.3 %
Asia 8.74 %
Other 1.84 %


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

IBM's Profile

Stock Price

IBM's Financials

Business Description

Fundamentals

Charts & Quotes

IBM's News

Suppliers

IBM's Competitors

Customers & Markets

Economic Indicators

IBM's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071